Laufer S - Search Results

1

Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents.

Cianni L, Lemke C, Gilberg E, Feldmann C, Rosini F, Rocho FDR, Ribeiro JFR, Tezuka DY, Lopes CD, de Albuquerque S, Bajorath J, Laufer S, Leitão A, Gütschow M, Montanari CA. Cianni L, et al. Among authors: laufer s. PLoS Negl Trop Dis. 2020 Mar 12;14(3):e0007755. doi: 10.1371/journal.pntd.0007755. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32163418 Free PMC article.

2

Assessing the target differentiation potential of imidazole-based protein kinase inhibitors.

Dimova D, Iyer P, Vogt M, Totzke F, Kubbutat MH, Schächtele C, Laufer S, Bajorath J. Dimova D, et al. Among authors: laufer s. J Med Chem. 2012 Dec 27;55(24):11067-71. doi: 10.1021/jm3014508. Epub 2012 Dec 11. J Med Chem. 2012. PMID: 23210446

3

Modeling of compound profiling experiments using support vector machines.

Balfer J, Heikamp K, Laufer S, Bajorath J. Balfer J, et al. Among authors: laufer s. Chem Biol Drug Des. 2014 Jul;84(1):75-85. doi: 10.1111/cbdd.12294. Epub 2014 Mar 13. Chem Biol Drug Des. 2014. PMID: 24472570

4

New frontiers in kinases: second generation inhibitors.

Laufer S, Bajorath J. Laufer S, et al. J Med Chem. 2014 Mar 27;57(6):2167-8. doi: 10.1021/jm500195x. Epub 2014 Mar 7. J Med Chem. 2014. PMID: 24606189 No abstract available.

5

Advancing the kinase field: new targets and second generation inhibitors.

Laufer S, Bajorath J. Laufer S, et al. J Med Chem. 2015 Jan 8;58(1):1. doi: 10.1021/jm5018708. Epub 2014 Dec 9. J Med Chem. 2015. PMID: 25490234 No abstract available.

6

Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.

Schwenck J, Maurer A, Fehrenbacher B, Mehling R, Knopf P, Mucha N, Haupt D, Fuchs K, Griessinger CM, Bukala D, Holstein J, Schaller M, Menendez IG, Ghoreschi K, Quintanilla-Martinez L, Gütschow M, Laufer S, Reinheckel T, Röcken M, Kalbacher H, Pichler BJ, Kneilling M. Schwenck J, et al. Among authors: laufer s. Theranostics. 2019 May 31;9(13):3903-3917. doi: 10.7150/thno.31037. eCollection 2019. Theranostics. 2019. PMID: 31281521 Free PMC article.

7

Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitors.

González-Medina M, Miljković F, Haase GS, Drueckes P, Trappe J, Laufer S, Bajorath J. González-Medina M, et al. Among authors: laufer s. Eur J Med Chem. 2020 Feb 1;187:112004. doi: 10.1016/j.ejmech.2019.112004. Epub 2019 Dec 20. Eur J Med Chem. 2020. PMID: 31881458

8

New Horizons in Drug Discovery - Understanding and Advancing Kinase Inhibitors.

Laufer S, Briner K, Bajorath J, Georg GI, Wang S. Laufer S, et al. J Med Chem. 2020 Aug 13;63(15):7921-7922. doi: 10.1021/acs.jmedchem.0c01136. Epub 2020 Jul 15. J Med Chem. 2020. PMID: 32668159 No abstract available.

9

Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationships.

Laufkötter O, Laufer S, Bajorath J. Laufkötter O, et al. Among authors: laufer s. Eur J Med Chem. 2020 Oct 15;204:112641. doi: 10.1016/j.ejmech.2020.112641. Epub 2020 Jul 18. Eur J Med Chem. 2020. PMID: 32745818

10

Kinase inhibitor data set for systematic analysis of representative kinases across the human kinome.

Laufkötter O, Laufer S, Bajorath J. Laufkötter O, et al. Among authors: laufer s. Data Brief. 2020 Aug 15;32:106189. doi: 10.1016/j.dib.2020.106189. eCollection 2020 Oct. Data Brief. 2020. PMID: 32904416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page